Cyclacel hosts Research and Development Day
The R&D day will feature renowned KOLs in oncology and program updates from senior management.
Do-
That
Triple board certified in hematology, oncology and internal medicine,
Her main research interests include gastric, pancreatic and bile duct cancer, with a particular interest in translational research and early drug development. She has published over 250 peer-reviewed journal articles and serves on numerous committees, including the
Around
Forward-Looking Statements
This press release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from historical results or from any future results expressed or implied by such forward-looking statements. Such forward-looking statements include, but are not limited to, statements regarding the efficacy, safety and intended use of
Contact:
Tel: (908) 517-7330
Email: [email protected]
Comments are closed.